Eli Lilly and Co's Zepbound has been approved by the FDA for the treatment of obstructive sleep apnea.

① The FDA in the USA approved Eli Lilly and Co's weight loss medication Zepbound on Friday for the treatment of obstructive sleep apnea (OSA), making it the first drug approved for directly treating this common sleep disorder; ② The active ingredient in Zepbound is Tirzepatide, which was initially used to treat type 2 diabetes, namely Eli Lilly and Co's Mounjaro.

cls.cnDec 22 11:45

Express News | Resmed Shares Down 5.2% Premarket After U.S. FDA Approves Lilly's Weight-Loss Drug for Sleep Apnea

Breakings36minutes ago

Citi Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Raises Target Price to $1,250

Futu NewsDec 21 18:33 · Ratings

Eli Lilly, Novo Nordisk Stocks Rise. One of These Obesity Drugmakers Just Hit a Landmark

Barron's20:49

Express News | RPT-Buzz-US Stocks Weekly: Snow Squall

Breakings19:00

These Stocks Are Moving the Most Today: Honda, Nissan, Qualcomm, Eli Lilly, Tesla, Rumble, and More -- Barrons.com

Barron's17:54